The latest in NIH COVID-19 treatment research
Though the COVID-19 vaccine is an critical instrument in halting the spread of the virus, therapies are still crucial to preserving lives all through the pandemic. Countrywide Institutes of Well being (NIH)-supported researcher Susan Baker, Ph.D., reports COVID-19 treatment plans via standard research. The investigate is part of NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) program. Dr. Baker spoke about some new results and what her hopes are for upcoming treatment plans of the virus that leads to COVID-19 and other viruses.
What is the target of your current COVID-19 therapy analysis?
We are hoping to discover new ways to end the virus. We are wanting at repurposing existing medicines and also starting off from scratch to determine a compound that would at some point be turned into a drug to fight COVID-19. We feel antiviral prescription drugs can be extremely effective, but it can get a extensive time